National Association of Testing Authorities, Australia
Scope of Accreditation
Dorevitch Pathology Healius Pathology Pty Ltd
Site
Heidelberg Laboratory – Healius Pathology Pty Ltd
Accreditation No.
2204
Site No.
2197
Date of Accreditation
30 Jun 1987
Contact
Mr Timothy Gunzburg P: +61 (03) 92440444
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Heidelberg Laboratory – Healius Pathology Pty Ltd
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Legal
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature |
Biochemistry
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Calculi | Ammonium; Calcium; Carbonate; Cholesterol; Cysteine; Magnesium; Oxalate; Phosphate; Silicon; Sulfate; Urate; Uric acid; Xanthine |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Tacrolimus |
| Cyclosporin | ||
| Plasma; Serum | Carbamazepine; Phenytoin (dilantin); Valproate (valproic acid, epilim) | |
| Lithium | ||
| Serum | Theophylline | |
| Digoxin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Other body fluids | Thyroglobulin |
| Plasma; Serum | Thyroglobulin | |
| Serum | Human chorionic gonadotropin (hCG) | |
| Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); α-Fetoprotein (AFP) | ||
| Serum; Urine | β2-Microglobulin (B2M) | |
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Fine needle aspirates (FNA) | Parathyroid hormone (PTH) |
| Plasma | Renin | |
| Plasma; Serum | Aldosterone | |
| Serum | C-peptide | |
| Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone - Total | ||
| 17α-Hydroxyprogesterone | ||
| Adrenocorticotropic hormone (ACTH) | ||
| Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Insulin | ||
| Androstenedione | ||
| Gastrin; Growth hormone | ||
| Urine | Androsterone; Dihydrotestosterone; Etiocholanolone; Pregnanediol; Pregnanetriol; Tetrahydro-11-dehydrocorticosterone; Tetrahydro-11-deoxycortisol; Tetrahydrocortisone | |
| Cortisol | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Serum | Fructosamine | |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
| Serum | Troponin I | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Serum | Lipoprotein subclasses | |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Bile acids - Quantitative |
| Serum | Haptoglobins; α1-Antitrypsin | |
| Caeruloplasmin; Prealbumin | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Other body fluids | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urea |
| Plasma | Ammonia; Lactate | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Glucose | ||
| Serum; Urine | Osmolality | |
| Urine | Calcium - Total; Chloride; Creatinine; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Iron studies | Plasma; Serum | Iron; Transferrin |
| Serum | Ferritin | |
| Chemical pathology - Markers of bone metabolism | Plasma; Serum | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | 25-Hydroxyvitamin D |
| Serum | Cobalamin (vitamin B12) | |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulation immunoglobulins |
| Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Rheumatoid factor |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Hev b5 - Latex; Ovomucoid - Egg; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicillin; Ampicilloyl group; Cefaclor; Chlorhexidine; Gelatin - Bovine; Morphine; Penicilloyl G; Penicilloyl V; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Budgerigar feathers; Caged bird mix; Cat dander; Cat epithelium; Chicken feathers; Dog dander; Feather mix; Guinea pig epithelium; Horse dander; Parrot feathers; Rabbit epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) | Serum | Cochineal extract (carmine red, E120) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk; Turkey meat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Abalone; Anchovy; Blue mussel; Clam; Codfish; Crab; Crayfish; Hake; Herring; Lobster; Mackerel; Octopus; Oyster; Red snapper; Salmon; Sardine (pilchard); Scallop; Seafood mix; Shrimp; Squid; Swordfish; Trout; Tuna; Whitefish (Inconnu) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Apricot; Asparagus; Avocado; Banana; Beetroot; Blueberry; Cabbage; Carrot; Celery; Cherry; Citrus mix; Cucumber; Date; Fig; Fruit mix; Garlic; Grape; Kiwi; Lemon citrus; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Onion; Orange citrus; Peach; Pear; Pineapple; Plum; Potato; Pumpkin; Raspberry; Spinach; Strawberry; Sweet potato; Tomato; Watermelon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Meat mix; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Casein; Cow milk; Goat milk; Milk; Sheep milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Chick pea; Coconut; Corn; Fenugreek; Foxtail; Green bean; Hazelnut; Lentil; Linseed; Lupin seed; Macadamia nut; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Quinoa; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Sweet chestnut; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Basil; Chilli pepper; Clove; Coriander (cilantro); Fennel seed; Ginger; Mint; Mustard; Paprika (sweet pepper); Spice mix; Thyme |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Barley; Bermuda grass; Cocksfoot; Grass mix; Johnson grass; Meadow grass; Rye grass; Timothy grass; Velvet grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Fire ant; German cockroach; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Candida albicans; Cladosporium herbarum; Penicillium chrysogenum (formerly Penicillium notatum); Staphylococcus enterotoxins; Trichophyton rubrum; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Glycyphagus domesticus storage mite; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Formaldehyde/formalin; Hexamethylene diisocyanate (1,6-hexamethylene diisocyanate; 1,6-HDI); Latex; Methylene diphenyl diisocyanate (MDI, isocyanate MDI, diphenylmethane diisocyanate); Sunflower seed; Toluene-2,4-diisocyanate (2,4-TDI) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; American beech; Australian pine; Box-elder; Cedar; Chestnut; Elm; Eucalyptus; European ash; Italian/Mediterranean/funeral cypress; Japanese cedar; London plane; Maple leaf sycamore; Melaleuca; Oak; Olive; Pine; Privet; Silver birch; Tree mix; White pine |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Common wasp allergen component; European hornet venom; European paper wasp venom; Honey bee venom; Paper wasp allergen component; Paper wasp venom; Yellow hornet venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Plantain - English; Rapeseed; Sheep sorrel; Sunflower; Weed mix; Western ragweed |
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Elastase |
| Plasma; Serum | Characterisation of cryoglobulins; Cryoglobulins | |
| Serum | Protein classes | |
| Protein classes | ||
| Detection and quantitation of free kappa and free lambda light chains | ||
| Urine | Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Serum | Total immunoglobulin E | |
| Immunoglobulin subclasses | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Helicobacter pylori |
Cytology
ISO 15189 (2022)
- This facility complies with the requirements of AS 5388.4 Forensic analysis Part 4: Reporting.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix; Liquid based cytology specimens from vaginal vault | Human papilloma virus (HPV) |
| Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material | ||
| Self-collected vaginal swabs | Human papilloma virus (HPV) |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices | ||
| Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Platelet function (PFA). |
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Fondaparinux; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Fragmin - Low molecular weight heparin; Anti-Xa activity - Heparin activity; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; Fibrinogen degradation products; International normalised ratio (INR); Platelet aggregation; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT); Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Lupus anticoagulant | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haemoglobin S (HbS) - Presence; Haemoglobin bands; Haemoglobin fraction (S, C, D, E) - Quantitation; Haemoglobin instability; Other abnormal haemoglobins; Presence of flocculation | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Fluids; Fresh tissue; Lavage; Lymphocyte subsets; Serous fluid | Assessment of lymphoid cell populations; Assessment of myeloid cell populations; B-cell; Blast cells; CD10; CD103; CD117; CD11a; CD11c; CD123; CD13; CD138; CD14; CD16; CD16/56; CD19; CD2; CD20; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD56; CD57; CD65; CD7; CD8; Cytoplasmic CD3 (cyCD3); FMC7; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Lambda light chains; Leukaemia screen; Lymphocyte surface markers; Lymphoma screen; Myeloma screen; Myeloperoxidase; Nuclear terminal deoxynucleotidyl transferase (NuTdT); Paroxysmal nocturnal haemoglobinuria (PNH) surface markers; Plasma cell; Total leucocyte number; Total lymphocyte number; cCD22; cCD3; cMPO; cyKappa; cyLambda |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
Histology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
| Review and reporting of biopsy material to identify or exclude morphological abnormalities | ||
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various |
Immunohaematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Kell system; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma; Serum | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Antibody elution | ||
| Blood; Plasma | Antibody titration | |
| Other blood group antibodies; Rh | ||
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies; Contamination - Microbiological |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products | Issue and release of blood and blood products for transfusion |
Micro Molecular
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal swabs; Sputum; Throat swabs | Legionella longbeachae; Legionella pneumophila |
| Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella pneumophila; Legionella spp.; Mycoplasma pneumoniae | ||
| Bacterial isolates | MecA/nuc gene; Van A/B | |
| Streptococcus agalactiae (Streptococcus group B) | ||
| Dry swabs | Treponema pallidum | |
| Dry swabs; Liquid based cytology specimens; Urine | Aeromonas spp.; Campylobacter spp.; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Escherichia coli; Neisseria gonorrhoeae; Salmonella spp.; Shigella spp.; Yersinia enterocolitica | |
| Faeces | Aeromonas spp.; Campylobacter spp.; Clostridioides difficile; Salmonella spp.; Shigella spp.; Yersinia spp. | |
| Genital swabs; Liquid based cytology specimens; Rectal swabs; Throat swabs; Urine | Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae; Trichomonas vaginalis | |
| Neisseria gonorrhoeae | ||
| Genital swabs; Rectal swabs; Throat swabs; Urine | Mycoplasma genitalium | |
| Genital swabs; Rectal swabs; Urine | Ureaplasma parvum; Ureaplasma urealyticum | |
| Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Bordetella parapertussis; Bordetella pertussis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis spp.; Cryptosporidium spp.; Dientamoeba fragilis; Entamoeba histolytica; Giardia spp. |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Cerebrospinal fluid (CSF); Dry swabs; Urine | Cytomegalovirus (CMV) |
| Blood; Dry swabs; Faeces | Enterovirus; Human parechovirus | |
| Bronchoalveolar lavage; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF) | Adenovirus; Enterovirus; Herpes simplex virus (HSV); Human parechovirus; Varicella zoster virus (VZV) | |
| Dry swabs | Adenovirus | |
| Enterovirus; Human parechovirus | ||
| Herpes simplex virus (HSV); Varicella zoster virus (VZV) | ||
| Faeces | Adenovirus F40; Adenovirus F41; Norovirus; Rotavirus | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Nasal swabs; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Picornavirus; Respiratory syncytial virus (RSV) A/B; Rhinovirus | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma; Serum | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load; Human immunodeficiency virus (HIV) RNA viral load |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Microbiology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of malabsorption | Faeces | Reducing substances |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Sperm number |
| Morphology; Motility; Sperm number | ||
| pH | ||
| Volume | ||
| Agglutination; Aggregation; Motility | ||
| Morphology | ||
| Liquefaction; Viscosity | ||
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Bacteria; Pathogenic identification and antibiotic susceptibility |
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Blood | Bacteria; Pathogenic microorganisms | |
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Sputum; Synovial fluid; Tissues; Urine | Bacteria; Pathogenic microorganisms | |
| Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Sputum; Synovial fluid; Tissues | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Fluids | Bacteria; Casts; Crystals; Epithelial cells; Leucocytes (white blood cells, WBC) | |
| Urine | Blood; Glucose; Ketones; Proteins; pH | |
| Legionella antigen | ||
| Bacteria; Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Blood; Glucose; Ketones; Proteins; pH | ||
| Streptococcus pneumoniae antigen | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags; Dialysis waters; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility |
| Environmental swabs | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Cerebrospinal fluid (CSF); Sputum; Tissues; Urine | Mycobacteria detection |
| Mycobacteria identification | ||
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF) | Cryptococcus antigen |
| General swabs; Hair; Nails; Skin scrapings; Sputum; Tissues | Fungi isolation; Yeast isolation | |
| Fungi detection; Yeast detection | ||
| Isolates | Yeast susceptibility | |
| Fungi identification; Yeasts identification | ||
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Helicobacter pylori |
Serology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Adalimumab; Infliximab |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-Jo-1 antibodies; Anti-La antibodies; Anti-Pm/Scl antibodies; Anti-Ro-52 antibodies; Anti-Ro-60 antibodies; Anti-Scl-70 antibodies; Anti-Smith antibodies (Sm); Anti-centromere protein A antibodies (Cenp-A); Anti-centromere protein B antibodies (Cenp-B); Anti-dense fine speckle 70 antibodies; Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-proliferating cell nuclear antigen (PCNA); Anti-ribonucleoprotein antibodies (RNP); Anti-ribosomal P protein antibodies |
| Serum | Anti-liver-kidney microsomes antibodies (LKM) | |
| Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-deamidated gliadin antibodies; Anti-tissue transglutaminase antibodies (tTG) | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-smooth muscle antibodies (SMA) | ||
| Tryptase | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Anti-nuclear antibodies (ANA) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Syphilis Treponema pallidum antibody |
| Epstein-Barr virus nuclear antigen; Epstein-Barr virus viral capsid antigen; Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Hepatitis B virus surface antibody (anti-HBs); Hepatitis C virus (HCV); Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody; Toxoplasma | ||
| Herpes simplex virus (HSV); Measles virus; Mumps virus; Mycoplasma pneumoniae; Parvovirus; Varicella zoster virus (VZV) | ||
| Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus (HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Serum | Barmah forest virus total antibody; Ross River virus | |
| Syphilis Treponema pallidum antibody | ||
| Cytomegalovirus (CMV) | ||
| Bordetella pertussis IgA; Bordetella pertussis IgG | ||
| Coxiella burnetii (Q-fever) total antibody | ||
| Chlamydia spp.; Chlamydial spp. IgG antibody; Chlamydial group IgA antibody |
Toxicology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Diazepam; Oxazepam; Temazepam |
| 6-Acetylmorphine; Amphetamines; Barbiturates; Benzodiazepines; Buprenorphine; Cannabis; Cocaine; Diazepam; Ethanol; Methadone; Methamphetamine; Opiates; Oxazepam; Phencyclidine; Propoxyphene; Temazepam; γ-Hydroxybutyric acid (GHB) | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Clozapine; Norclozapine |
| Urine | Ethylglucuronide (ETG) |
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Legal
Medicare expiry date
28 Feb 2026
Last Activity Date
27 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates; Oxidants; Specific gravity; Urea; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures | Urine | Amphetamines; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine |
| 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; Ephedrine | ||
| 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Cocaine; Codeine; Codeine-6-glucuronide (codeine-6-β-D-glucuronide); Diazepam; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Morphine-3-glucuronide (morphine-3-β-D-glucuronide); Morphine-6-glucuronide (morphine-6-β-D-glucuronide); Norbuprenorphine; Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Temazepam; α-Hydroxyalprazolam |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2204
Site No.
2197
Print date
26 Nov 2024
END OF SCOPE